Quoted Micro 28 August 2023
AQUIS STOCK EXCHANGE Pharma C Investments (PCIL) has received a general meeting requisition from one of its shareholders. The directors are reviewing the request. Technology marketing start-up Inteliqo (IQO) generated income of more than $400,000 and pre-tax profit of $250,000 from the distribution rights of the Langaroo app, which has still to be launched on […]
Quoted Micro 20 February 2023
AQUIS STOCK EXCHANGE EDX Medical Group (EDX) acquired Torax Biosciences for the issue of 1.67 million shares at a notional 6p each. Torax provides development and pilot scale fabrication of immunochemistry-based assays and diagnostic testing services. The experienced team at Torax was an attraction. Marula Mining (MARU) signed a co-development and relationship agreement with a […]
Quoted Micro 17 October 2022
AQUIS STOCK EXCHANGE Invinity Energy Systems (IES) is having a good week. Early in the week it announced a sale of a a 0.8MWh Invinity VS3 flow battery system to Equans Belux and then it won a California Energy Commission project as part of a consortium developing a large solar-plus-storage microgrid. Invinity Energy Systems will […]
Quoted Micro 26 September 2022
AQUIS STOCK EXCHANGE Interim results from renewable energy supplier Good Energy (GOOD) show a jump in revenues, but a fall in gross profit because of tough margin comparisons. There was a pre-tax loss, but a tax credit meant that there was a profit after tax. The supply business is hedged for the second half of […]
Quoted Micro 19 September 2022
AQUIS STOCK EXCHANGE ProBiotix Health (PBX) has secured a new commercial partner in Asia Pacific. Nutraceutical business Nutraconnect will develop and implement strategies for ProBiotix Health ingredients in Asia Pacific. IamFire (FIRE) says investee company WeShop Holdings had 23,000 user downloads by the end of August. Transactions increased from 2,633 in July to 5,981 in […]
Quoted Micro 5 September 2022
AQUIS STOCK EXCHANGE Cancer treatments developer Incanthera (INC) says that commercial discussions continue for skin cancer treatment Sol and there is potential for a Sol-based product range. There is still £295,000 of cash in the balance sheet at the end of March 2022. The Actino-Pro brand has been trademarked. There was a cash outflow from […]